These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 26300544)

  • 1. OPRK1 promoter hypermethylation increases the risk of Alzheimer's disease.
    Ji H; Wang Y; Liu G; Xu X; Dai D; Chen Z; Zhou D; Zhou X; Han L; Li Y; Zhuo R; Hong Q; Jiang L; Zhang X; Liu Y; Xu L; Chang L; Li J; An P; Duan S; Wang Q
    Neurosci Lett; 2015 Oct; 606():24-9. PubMed ID: 26300544
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of OPRK1 and OPRM1 methylation with mild cognitive impairment in Xinjiang Han and Uygur populations.
    Liu G; Ji H; Liu J; Xu C; Chang L; Cui W; Ye C; Hu H; Chen Y; Zhou X; Duan S; Wang Q
    Neurosci Lett; 2017 Jan; 636():170-176. PubMed ID: 27838450
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevated OPRD1 promoter methylation in Alzheimer's disease patients.
    Ji H; Wang Y; Liu G; Chang L; Chen Z; Zhou D; Xu X; Cui W; Hong Q; Jiang L; Li J; Zhou X; Li Y; Guo Z; Zha Q; Niu Y; Weng Q; Duan S; Wang Q
    PLoS One; 2017; 12(3):e0172335. PubMed ID: 28253273
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevated DRD4 promoter methylation increases the risk of Alzheimer's disease in males.
    Ji H; Wang Y; Jiang D; Liu G; Xu X; Dai D; Zhou X; Cui W; Li J; Chen Z; Li Y; Zhou D; Zha Q; Zhuo R; Jiang L; Liu Y; Shen L; Zhang B; Xu L; Hu H; Zhang Y; Yin H; Duan S; Wang Q
    Mol Med Rep; 2016 Sep; 14(3):2732-8. PubMed ID: 27485706
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elevated methylation of OPRM1 and OPRL1 genes in Alzheimer's disease.
    Xu C; Liu G; Ji H; Chen W; Dai D; Chen Z; Zhou D; Xu L; Hu H; Cui W; Chang L; Zha Q; Li L; Duan S; Wang Q
    Mol Med Rep; 2018 Nov; 18(5):4297-4302. PubMed ID: 30152845
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Methylation analysis of SST and SSTR4 promoters in the neocortex of Alzheimer's disease patients.
    Grosser C; Neumann L; Horsthemke B; Zeschnigk M; van de Nes J
    Neurosci Lett; 2014 Apr; 566():241-6. PubMed ID: 24602981
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CRTC1 gene is differentially methylated in the human hippocampus in Alzheimer's disease.
    Mendioroz M; Celarain N; Altuna M; Sánchez-Ruiz de Gordoa J; Zelaya MV; Roldán M; Rubio I; Larumbe R; Erro ME; Méndez I; Echávarri C
    Alzheimers Res Ther; 2016 Apr; 8(1):15. PubMed ID: 27094739
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypermethylation of the κ1 opioid receptor promoter in Chinese heroin and methamphetamine addicts.
    Ji H; Liu G; Xu X; Liu H; Xu L; Hu H; Chen Y; Hong Q; Wang Q; Shen W; Li L; Xie X; Zhou W; Duan S
    Exp Ther Med; 2018 Sep; 16(3):2392-2398. PubMed ID: 30210591
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elevation of peripheral BDNF promoter methylation links to the risk of Alzheimer's disease.
    Chang L; Wang Y; Ji H; Dai D; Xu X; Jiang D; Hong Q; Ye H; Zhang X; Zhou X; Liu Y; Li J; Chen Z; Li Y; Zhou D; Zhuo R; Zhang Y; Yin H; Mao C; Duan S; Wang Q
    PLoS One; 2014; 9(11):e110773. PubMed ID: 25364831
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DNA methylation level of the neprilysin promoter in Alzheimer's disease brains.
    Nagata K; Mano T; Murayama S; Saido TC; Iwata A
    Neurosci Lett; 2018 Mar; 670():8-13. PubMed ID: 29339171
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aberrant methylation and silencing of ARHI, an imprinted tumor suppressor gene in which the function is lost in breast cancers.
    Yuan J; Luo RZ; Fujii S; Wang L; Hu W; Andreeff M; Pan Y; Kadota M; Oshimura M; Sahin AA; Issa JP; Bast RC; Yu Y
    Cancer Res; 2003 Jul; 63(14):4174-80. PubMed ID: 12874023
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methylation analysis of multiple genes in blood DNA of Alzheimer's disease and healthy individuals.
    Tannorella P; Stoccoro A; Tognoni G; Petrozzi L; Salluzzo MG; Ragalmuto A; Siciliano G; Haslberger A; Bosco P; Bonuccelli U; Migliore L; Coppedè F
    Neurosci Lett; 2015 Jul; 600():143-7. PubMed ID: 26079324
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation between the single-site CpG methylation and expression silencing of the XAF1 gene in human gastric and colon cancers.
    Zou B; Chim CS; Zeng H; Leung SY; Yang Y; Tu SP; Lin MC; Wang J; He H; Jiang SH; Sun YW; Yu LF; Yuen ST; Kung HF; Wong BC
    Gastroenterology; 2006 Dec; 131(6):1835-43. PubMed ID: 17087954
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of Biomarkers Based on DNA Methylation in the NCAPH2/LMF2 Promoter Region for Diagnosis of Alzheimer's Disease and Amnesic Mild Cognitive Impairment.
    Kobayashi N; Shinagawa S; Nagata T; Shimada K; Shibata N; Ohnuma T; Kasanuki K; Arai H; Yamada H; Nakayama K; Kondo K
    PLoS One; 2016; 11(1):e0146449. PubMed ID: 26742120
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PLD3 epigenetic changes in the hippocampus of Alzheimer's disease.
    Blanco-Luquin I; Altuna M; Sánchez-Ruiz de Gordoa J; Urdánoz-Casado A; Roldán M; Cámara M; Zelaya V; Erro ME; Echavarri C; Mendioroz M
    Clin Epigenetics; 2018 Sep; 10(1):116. PubMed ID: 30208929
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of AGTR1 Promoter Methylation Levels with Essential Hypertension Risk: A Matched Case-Control Study.
    Fan R; Mao S; Zhong F; Gong M; Yin F; Hao L; Zhang L
    Cytogenet Genome Res; 2015; 147(2-3):95-102. PubMed ID: 26658476
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gene Expression and Methylation Analysis of ABCA7 in Patients with Alzheimer's Disease.
    Yamazaki K; Yoshino Y; Mori T; Yoshida T; Ozaki Y; Sao T; Mori Y; Ochi S; Iga JI; Ueno SI
    J Alzheimers Dis; 2017; 57(1):171-181. PubMed ID: 28222527
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of Cerebellum-Specific Ribosomal DNA Epigenetic Modifications in Alzheimer's Disease: Should the Cerebellum Serve as a Control Tissue After All?
    Faria TC; Maldonado HL; Santos LC; DeLabio R; Payao SLM; Turecki G; Mechawar N; Santana DA; Gigek CO; Lemos B; Smith MAC; Chen ES
    Mol Neurobiol; 2020 Jun; 57(6):2563-2571. PubMed ID: 32232768
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Promoter methylation of P16, RARbeta, E-cadherin, cyclin A1 and cytoglobin in oral cancer: quantitative evaluation using pyrosequencing.
    Shaw RJ; Liloglou T; Rogers SN; Brown JS; Vaughan ED; Lowe D; Field JK; Risk JM
    Br J Cancer; 2006 Feb; 94(4):561-8. PubMed ID: 16449996
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peripheral leukocyte expression of the potential biomarker proteins Bdnf, Sirt1, and Psen1 is not regulated by promoter methylation in Alzheimer's disease patients.
    Carboni L; Lattanzio F; Candeletti S; Porcellini E; Raschi E; Licastro F; Romualdi P
    Neurosci Lett; 2015 Sep; 605():44-8. PubMed ID: 26275347
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.